Avran.jpg

Pacific Eye Instruments is a distributor of premium new and used ophthalmic medical devices in California and Nevada

425-750-2464

avram@paceyes.com

PRESIDENT

AVRAM DOLEN

Contact us

©  2019  Pacific Eye Instruments | Privacy Policy  |  Terms and Conditions | Design and SEO Rossane Costa|

 

Elektron Eye Technology 
Ophthalmic instruments for the detection and monitoring of glaucoma and age related macular degeneration.

The evolution of ophthalmic equipment

MPS II

  • Low macular pigment is a key modifiable risk factor for the development of age-related macular degeneration (AMD).

  • The MPS II is a fast, portable screener for measuring macular pigment optical density (MPOD) and monitoring its changes over time. Proven to deliver reproducible results, the MPS II is innovative and clinically relevant, enabling a preventative approach to managing the global problem of macular degeneration.

Added value for patients & practitioners 

the Macular Pigment Screener (MPS II) is a key enabler in such an approach.It helps patients by identifying and monitoring macular pigment levels over time and supports professionals with the diversification of eye health services. It is:

  • Reliable scientifically validated through use in multiple studies

  • Repeatable  has accurately measured more than 4 million eyes

  • Intuitive easy-to-use user interface with icon-driven menus

  • Fast  screen in 90 seconds per eye for efficient patient care

  • Commercially viable clear ROI through test fees and suplement sales

Macular Pigment Screening

MPS II

Macular pigment monitoring with the MPS II

  • Now eye care professionals can take a proactive, preventative approach to the growing global problem of age-related macular degeneration (AMD).

  • Measuring macular pigment optical density (MPOD) – a significant and modifiable risk factor for AMD – the MPS II provides results at speeds as fast as 90 seconds per eye.

    “The MPS II is the quickest, most affordable, and most clinically relevant ophthalmic device in the world. It provides an efficient method for determining macular pigment optical density in everyday optometric and ophthalmological practice. I believe it will revolutionize the practice of eye care.“
    Stuart P. Richer, OD, PhD
    Director, Ocular Preventive Medicine
    Captain James A Lovell Federal Healthcare Facility, Chicago, USA

A proactive approach to a global issue

Age-related macular degeneration (AMD) is a growing global socioeconomic threat, but there are ways to prevent or mitigate its impact. By adopting a proactive approach to fighting the condition, eye care professionals can identify and help those most at risk before more serious intervention is necessary.

Detect Macular Degeneration Risk Early